Cough Variant Asthma Medical Services in China

Cough Variant Asthma (CVA) is a phenotypic subtype of bronchial asthma characterized predominantly by chronic, non-productive cough lasting more than eight weeks, without classic wheezing or dyspnea. It results from airway hyperresponsiveness and eosinophilic inflammation, often triggered by allergens, viral infections, or environmental irritants. Diagnosis requires exclusion of other causes—such as GERD, postnasal drip, or chronic bronchitis—and confirmation via bronchial provocation testing (e.g., methacholine challenge) or therapeutic response to inhaled corticosteroids and bronchodilators. Left untreated, CVA may progress to typical asthma in up to 30% of cases over several years. Early intervention with low-dose inhaled corticosteroids (ICS), often combined with long-acting beta-agonists (LABA), yields high remission rates and prevents structural airway remodeling.

China offers distinct advantages for CVA management: leading respiratory centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—employ advanced pulmonary function labs, fractional exhaled nitric oxide (FeNO) monitoring, and AI-assisted spirometry interpretation. Clinical experience is extensive, with published success rates exceeding 90% in symptom control within 12 weeks. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or medication quality. As a dedicated medical tourism agency, we facilitate seamless access for international patients: arranging consultations with certified pulmonologists, securing appointments at JCI-accredited hospitals, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and medical translation to post-treatment follow-up coordination.

Medical Travel to China Guide: Cough-Variant Asthma (Respiratory Medicine)

Most nationalities require a Chinese visa; we assist with invitation letters from partner hospitals and guide you through the application process. Upon arrival, present your passport, visa, and medical appointment confirmation at immigration. For treatment, international health insurance is often not accepted in China; however, our agency provides transparent, all-inclusive pricing upfront—covering consultations, pulmonary function tests, bronchial provocation testing, and personalized inhaler therapy. We accept wire transfers, credit cards (with 3% processing fee), and third-party medical financing options. Accommodation near top-tier respiratory hospitals (e.g., Peking Union Medical College Hospital) is arranged with verified hotels offering medical-grade amenities; companions are welcome and may stay at no extra cost in designated family rooms. Post-treatment, our dedicated care coordinators schedule virtual follow-ups every 2–4 weeks for 3 months, review symptom diaries and peak flow readings, adjust medication plans with your home physician’s input, and provide bilingual discharge summaries and prescription translations. All services—including visa support, payment coordination, lodging, and remote monitoring—are managed end-to-end by our bilingual medical travel team to ensure continuity of care across borders.